Approvals/CIMA-AEMPS/ULTOMIRIS 300 mg/3 ml CONCENTRADO PARA SOLUCION PARA PERFUSION

Approved

STANDARD

ULTOMIRIS 300 mg/3 ml CONCENTRADO PARA SOLUCION PARA PERFUSION

Alexion Europe Sas🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Id: 39c42042cf0d5136
Drug Cima Aemps Name: ULTOMIRIS 300 mg/3 ml CONCENTRADO PARA SOLUCION PARA PERFUSION
Register Number: 1191371002
Holder Company Name: Alexion Europe Sas
Marketing Company Name: Alexion Pharma Spain S.L.U.
Holder Company Detail Path: /organization/alexion-europe-sas
Authorization Date: 2021-06-10
Dosage Form: CONCENTRADO PARA SOLUCIÓN PARA PERFUSIÓN
Dose: 300 mg/3 ml
Route Of Administration: VÍA INTRAVENOSA
Prescription Type: Uso Hospitalario
Commercialized: Yes
Company Name: Alexion Europe Sas
Company Detail Path: /organization/alexion-europe-sas

RAVULIZUMAB

300 mg

Approved

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

Jun 10, 2021

Approval ID

39c42042cf0d5136

Type

Standard